This session was presented on Day 1, June 20th 2025 of the 85th American Diabetes Association Scientific Sessions, held in Chicago, IL by Dr. Samantha
This session was presented on Day 1, June 20th 2025 of the 85th American Diabetes Association Scientific Sessions, held in Chicago, IL by Dr. Shawn
This session was presented on Day 1, June 20th 2025 of the 85th American Diabetes Association Scientific Sessions, held in Chicago, IL by Dr. Junfang
This session was presented on Day 1, June 20th 2025 of the 85th American Diabetes Association Scientific Sessions, held in Chicago, IL by Dr. Jamy
The approval of tirzepatide, the first dual incretin agonist, for the treatment of type 2 diabetes ushered in a “new era of metabolic medicine,” according
In type 2 diabetes, ARMMS-T2D is the largest and longest-running comparison of metabolic surgery versus medical and lifestyle intervention. In a symposium held on Monday,
This paper was presented on June 25 at the 83 American Diabetes Association ( ADA) Annual Scientific Session at San Diego by Drs Yong Soo
This paper was presented on June 25 at the 83 American Diabetes Association ( ADA) Annual Scientific Session at San Diego by Drs James Amamoo,
According to new research, positive discordance as measured by a glycation ratio of glucose management indicator and haemoglobin A1c (GMI/A1c) was associated with a risk
On June 26 2023, the American Diabetes Association® (ADA) presented Carmella Evans-Molina, MD, PhD, Eli Lilly Professor of Paediatric Diabetes, Indiana University (IU) School of